Holdings of ALPS Medical Breakthroughs ETF
ALPS ETF TRUST · Original filing · Compare with another fund · Report an error
- Net assets
- 138M $ including 138M $ in equities, 100.0 %
- Positions
- 85 in 8 countries
- Top ten
- 30.5 % of net assets
- Filed on
- Feb 28, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Kymera Therapeutics Inc | 70,365 | 6.4M $ | 4.66 % |
| 2 | Celcuity Inc | 41,241 | 4.6M $ | 3.34 % |
| 3 | Alkermes PLC | 147,168 | 4.4M $ | 3.21 % |
| 4 | CG oncology Inc | 71,897 | 4.2M $ | 3.06 % |
| 5 | Mirum Pharmaceuticals Inc | 45,804 | 4.2M $ | 3.06 % |
| 6 | Amicus Therapeutics Inc | 274,988 | 4M $ | 2.86 % |
| 7 | ACADIA Pharmaceuticals Inc | 150,789 | 3.7M $ | 2.68 % |
| 8 | Newamsterdam Pharma Co NV | 101,063 | 3.6M $ | 2.60 % |
| 9 | Crinetics Pharmaceuticals Inc | 84,576 | 3.5M $ | 2.52 % |
| 10 | Apogee Therapeutics Inc | 48,872 | 3.4M $ | 2.48 % |
| 11 | Viking Therapeutics Inc | 100,746 | 3.4M $ | 2.47 % |
| 12 | Structure Therapeutics Inc | 54,083 | 3.4M $ | 2.47 % |
| 13 | Xenon Pharmaceuticals Inc | 68,873 | 3M $ | 2.16 % |
| 14 | Spyre Therapeutics Inc | 69,157 | 3M $ | 2.15 % |
| 15 | Edgewise Therapeutics Inc | 94,360 | 2.9M $ | 2.08 % |
| 16 | Tarsus Pharmaceuticals Inc | 37,835 | 2.9M $ | 2.07 % |
| 17 | Denali Therapeutics Inc | 131,033 | 2.8M $ | 2.01 % |
| 18 | Ideaya Biosciences Inc | 78,135 | 2.5M $ | 1.82 % |
| 19 | Travere Therapeutics Inc | 79,744 | 2.4M $ | 1.72 % |
| 20 | Apellis Pharmaceuticals Inc | 112,768 | 2.4M $ | 1.71 % |
| 21 | Vera Therapeutics Inc | 56,977 | 2.3M $ | 1.68 % |
| 22 | Disc Medicine Inc | 33,646 | 2.2M $ | 1.62 % |
| 23 | Dianthus Therapeutics Inc | 38,214 | 2.1M $ | 1.53 % |
| 24 | Mineralys Therapeutics Inc | 70,537 | 2.1M $ | 1.50 % |
| 25 | Galapagos NV | 58,387 | 2M $ | 1.42 % |
| 26 | Maze Therapeutics Inc | 42,889 | 2M $ | 1.42 % |
| 27 | ZAI LAB LTD | 99,972 | 1.9M $ | 1.39 % |
| 28 | Stoke Therapeutics Inc | 50,908 | 1.9M $ | 1.34 % |
| 29 | Nuvation Bio Inc | 305,559 | 1.8M $ | 1.31 % |
| 30 | Celldex Therapeutics Inc | 59,226 | 1.8M $ | 1.29 % |
| 31 | Olema Pharmaceuticals Inc | 70,109 | 1.7M $ | 1.23 % |
| 32 | Pharvaris NV | 57,094 | 1.6M $ | 1.17 % |
| 33 | Vericel Corp | 45,076 | 1.6M $ | 1.17 % |
| 34 | Relay Therapeutics Inc | 154,480 | 1.6M $ | 1.15 % |
| 35 | Tyra Biosciences Inc | 47,570 | 1.6M $ | 1.15 % |
| 36 | Agios Pharmaceuticals Inc | 51,973 | 1.6M $ | 1.14 % |
| 37 | Sarepta Therapeutics Inc | 93,395 | 1.6M $ | 1.13 % |
| 38 | Oculis Holding AG | 50,955 | 1.5M $ | 1.09 % |
| 39 | Amylyx Pharmaceuticals Inc | 97,879 | 1.5M $ | 1.08 % |
| 40 | Oruka Therapeutics Inc | 43,144 | 1.5M $ | 1.08 % |
| 41 | Novavax Inc | 144,833 | 1.5M $ | 1.06 % |
| 42 | Immunocore Holdings PLC | 45,035 | 1.5M $ | 1.05 % |
| 43 | Sionna Therapeutics Inc | 39,776 | 1.5M $ | 1.05 % |
| 44 | Palvella Therapeutics Inc | 10,552 | 1.4M $ | 1.03 % |
| 45 | MBX Biosciences Inc | 40,022 | 1.3M $ | 0.94 % |
| 46 | ZENAS BIOPHARMA INC | 47,842 | 1.3M $ | 0.91 % |
| 47 | IMMATICS NV | 119,488 | 1.2M $ | 0.90 % |
| 48 | Rapport Therapeutics Inc | 42,477 | 1.2M $ | 0.89 % |
| 49 | Corvus Pharmaceuticals Inc | 66,564 | 1.2M $ | 0.88 % |
| 50 | Taysha Gene Therapies Inc | 244,138 | 1.1M $ | 0.80 % |
| 51 | MoonLake Immunotherapeutics | 63,143 | 1.1M $ | 0.80 % |
| 52 | Day One Biopharmaceuticals Inc | 91,514 | 970K $ | 0.70 % |
| 53 | Geron Corp | 568,951 | 955.8K $ | 0.69 % |
| 54 | MannKind Corp | 273,687 | 897.7K $ | 0.65 % |
| 55 | Compass Therapeutics Inc | 158,523 | 895.7K $ | 0.65 % |
| 56 | ArriVent Biopharma Inc | 36,792 | 845.1K $ | 0.61 % |
| 57 | Theravance Biopharma Inc | 45,164 | 824.2K $ | 0.60 % |
| 58 | Bicara Therapeutics Inc | 48,826 | 819.3K $ | 0.59 % |
| 59 | ARS Pharmaceuticals Inc | 88,100 | 817.6K $ | 0.59 % |
| 60 | Xencor Inc | 63,648 | 812.8K $ | 0.59 % |
| 61 | KalVista Pharmaceuticals Inc | 45,051 | 733.4K $ | 0.53 % |
| 62 | Kura Oncology Inc | 77,558 | 677.1K $ | 0.49 % |
| 63 | Rigel Pharmaceuticals Inc | 16,180 | 562.1K $ | 0.41 % |
| 64 | Alto Neuroscience Inc | 27,688 | 545.2K $ | 0.40 % |
| 65 | Design Therapeutics Inc | 50,771 | 530K $ | 0.38 % |
| 66 | Vanda Pharmaceuticals Inc | 52,672 | 469.3K $ | 0.34 % |
| 67 | Fulgent Genetics Inc | 27,554 | 422.4K $ | 0.31 % |
| 68 | REGENXBIO Inc | 45,118 | 407.9K $ | 0.30 % |
| 69 | Altimmune Inc | 92,999 | 400.8K $ | 0.29 % |
| 70 | Tectonic Therapeutic Inc | 16,682 | 391.2K $ | 0.28 % |
| 71 | Zura Bio Ltd | 57,952 | 383.6K $ | 0.28 % |
| 72 | Upstream Bio Inc | 48,162 | 369.9K $ | 0.27 % |
| 73 | Anavex Life Sciences Corp | 79,635 | 352.8K $ | 0.26 % |
| 74 | Forte Biosciences Inc | 11,166 | 337.4K $ | 0.24 % |
| 75 | Atea Pharmaceuticals Inc | 69,634 | 325.9K $ | 0.24 % |
| 76 | Neurogene Inc | 13,806 | 324.3K $ | 0.24 % |
| 77 | Akebia Therapeutics Inc | 236,514 | 309.8K $ | 0.22 % |
| 78 | Protara Therapeutics Inc | 46,015 | 292.7K $ | 0.21 % |
| 79 | Delcath Systems Inc | 31,472 | 280.1K $ | 0.20 % |
| 80 | Aclaris Therapeutics Inc | 96,567 | 277.1K $ | 0.20 % |
| 81 | Rezolute Inc | 82,647 | 265.3K $ | 0.19 % |
| 82 | Candel Therapeutics Inc | 48,929 | 256.9K $ | 0.19 % |
| 83 | Bicycle Therapeutics PLC | 44,503 | 255K $ | 0.18 % |
| 84 | Aardvark Therapeutics Inc | 19,407 | 242.4K $ | 0.18 % |
| 85 | Arcturus Therapeutics Holdings Inc | 25,324 | 208.4K $ | 0.15 % |
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 84.8 %
- Netherlands 4.7 %
- Ireland 3.2 %
- Cayman Islands 2.5 %
- Canada 2.2 %
- Belgium 1.4 %
- Switzerland 1.1 %
- United Kingdom 0.2 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 74 | 117M $ | 84.80 % |
| 2 | Netherlands | 3 | 6.4M $ | 4.67 % |
| 3 | Ireland | 1 | 4.4M $ | 3.21 % |
| 4 | Cayman Islands | 3 | 3.4M $ | 2.47 % |
| 5 | Canada | 1 | 3M $ | 2.16 % |
| 6 | Belgium | 1 | 2M $ | 1.42 % |
| 7 | Switzerland | 1 | 1.5M $ | 1.09 % |
| 8 | United Kingdom | 1 | 255K $ | 0.18 % |
Cite this page
Titelia. "Holdings of ALPS Medical Breakthroughs ETF". https://titelia.com/en/funds/S000047823